Nicola Abate is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4002 Garth Rd Ste 120
Baytown, TX 775213179
Telephone
281-628-7240Provider last certified this registry record 4 Oct 2022.
Clinical trials
- Caduet and TLC Intervention in Metabolic Syndrome
Sponsor: The University of Texas Medical Branch, Galveston
- Fatty Liver Study in Patients With Type II Diabetes
Sponsor: The University of Texas Medical Branch, Galveston
- Effect of Lycopene and Isoflavones on Glucose Metabolism
Sponsor: The University of Texas Medical Branch, Galveston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
54 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20254 payments
- Novo Nordisk IncProgram year20255 payments
- Amgen Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
64.8%Insulin Analog14.4%Soliqua 100-3329%Lantus Solostar11%Tresiba Flextouch U-20010%Tresiba Flextouch U-1008%Humalog Kwikpen U-1006%Toujeo Max Solostar6%Fiasp Flextouch5%Humalog4%Novolog3%Humalog Kwikpen U-2003%Insulin Lispro3%Toujeo Solostar3%Novolog Flexpen3%Lantus2%Levemir Flexpen2%Basaglar Kwikpen U-1002%Levemir2%Part D<11 patientsGLP-1 receptor agonist14%Ozempic52%Mounjaro40%Trulicity5%Rybelsus4%Part D<11 patients+ 9 more classes in this area
Cardiovascular
19.8%Statin8.6%Rosuvastatin Calcium51%Atorvastatin Calcium43%Pravastatin Sodium4%Simvastatin3%Part D<11 patientsACE inhibitor2.4%Lisinopril79%Lisinopril-Hydrochlorothiazide21%Part D<11 patients+ 9 more classes in this area
Hormonal (systemic)
11.2%l-Thyroxine9.8%Levothyroxine Sodium88%Synthroid12%Part D≥133 patientsThyroid Hormone Synthesis Inhibitor1.5%Methimazole100%Part D≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
5 NIH research awards on record, funded 1999–2009 per NIH RePORTER. The latest:
- Role of ENPP1 in insulin resistance without obesity
University of Texas Med Br Galveston
FY2009$278,233R01DK072158 - ROLE OF ENPP1 IN INSULIN RESISTANCE WITHOUT OBESITY
Ut Southwestern Medical Center
FY2009$17,838P41RR002584 - A PILOT STUDY ON TREATMENT EFFECT OF TOMATO LYCOPENE AND SOY ISOFLAVONES ON
University of Texas Med Br Galveston
FY2009$5,881M01RR000073
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”